[HTML] mdpi.com

[HTML][HTML] Predictive biomarkers of immune checkpoint inhibitor response in breast cancer: looking beyond tumoral PD-L1

N Chen, N Higashiyama, V Hoyos - Biomedicines, 2021 - mdpi.com
Immune checkpoint inhibitors utilize the immune system to kill cancer cells and are now
widely applied across numerous malignancies. Pembrolizumab has two breast-specific …
被引用次数：12 相关文章

Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Breast Cancer: Looking beyond Tumoral PD-L1

N Chen, N Higashiyama, V Hoyos - Biomedicines, 2021 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors utilize the immune system to kill cancer cells and are now
widely applied across numerous malignancies. Pembrolizumab has two breast-specific …

Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Breast Cancer: Looking beyond Tumoral PD-L1

N Chen, N Higashiyama, V Hoyos - Biomedicines, 2021 - search.proquest.com
Immune checkpoint inhibitors utilize the immune system to kill cancer cells and are now
widely applied across numerous malignancies. Pembrolizumab has two breast-specific …
[HTML] nih.gov

[HTML][HTML] Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Breast Cancer: Looking beyond Tumoral PD-L1

N Chen, N Higashiyama, V Hoyos - Biomedicines, 2021 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors utilize the immune system to kill cancer cells and are now
widely applied across numerous malignancies. Pembrolizumab has two breast-specific …

Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Breast Cancer: Looking beyond Tumoral PD-L1.

N Chen, N Higashiyama, V Hoyos - Biomedicines, 2021 - search.ebscohost.com
Immune checkpoint inhibitors utilize the immune system to kill cancer cells and are now
widely applied across numerous malignancies. Pembrolizumab has two breast-specific …

Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Breast Cancer: Looking beyond Tumoral PD-L1

N Chen, N Higashiyama, V Hoyos - 2021 - agris.fao.org
Immune checkpoint inhibitors utilize the immune system to kill cancer cells and are now
widely applied across numerous malignancies. Pembrolizumab has two breast-specific …

Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Breast Cancer: Looking beyond Tumoral PD-L1.

N Chen, N Higashiyama, V Hoyos - Biomedicines, 2021 - europepmc.org
Immune checkpoint inhibitors utilize the immune system to kill cancer cells and are now
widely applied across numerous malignancies. Pembrolizumab has two breast-specific …